ABSTRACT. To clarify the role of nitric oxide (NO) in hemodialysis (HD)-related hypotension, the relationship between plasma NO metabolites (NOx) and blood pressure changes, and the effect of N G -monomethyl-L-arginine (L-NMMA), a NO synthase inhibitor, on changes in blood pressure were evaluated in an experimental renal dysfunctional dog model. In order to create a renal dysfunction model, gentamicin was administered to male beagles in which 7 of 8 renal artery branches had been ligated. Normal renal functional and dy sfunctional dogs underwent 3 hr of HD per day for 3 days. HD induced a transient decrease in mean blood pressure in the normal renal functional dogs. In renal dysfunctional dogs, a continuous hypotension occurred with a gradual increase in the plasma NOx conce ntration during HD. Although L-NMMA prevented the fall in blood pressure, it did not significantly change the plasma NOx concentration during HD. These results suggest that NO contributes to HD-related hypotension in renal dysfunctional dogs but the plasma NOx concentration does not reflect the change in blood pressure. KEY WORDS: hemodialysis-related hypotension, L-NMMA, nitric oxide, renal dysfunctional dog.
Hemodialysis (HD) is an established form of therapy for renal dysfunction which has developed since the first study was carried out on a rabbit in 1912 [1] . Nevertheless, HD causes many complications. Hypotension is a major complication of HD that often requires aggressive resuscitation and premature termination of HD. It is widely accepted that many factors influence HD-related hypotension [5] .
Nitric oxide (NO) is an endogenous vasodilator and an increase in NO synthesis is known to decrease the blood pressure [8, 14] . There are some reports suggesting that NO may contribute to HD-related hypotension. It has been shown that there is a correlation between the increase in levels of plasma nitrates and nitrites (NOx) and the reduction in blood pressure in HD patients [12, 15] . Methylene blue, a NO inhibitor, prevented hypotension in a few patients undergoing HD therapy [18] , but it was conceivable that basic examination concerning an involvement of NO in HDrelated hypotension was insufficient. Interleukin-1 (IL-1) and tumor necrosis factor (TNF) are powerful inducers of the inducible form of NO synthase (iNOS) [6] , which causes overproduction of NO [19] , and activate constitutive endothelial NO synthase (eNOS) [3] . Plasma levels of these cytokines chronically increase in renal disease patients undergoing HD therapy [6] . The cause may be partly attributable to decreased renal clearance [20] . These results suggest that the ability to produce NO in renal dysfunction is greater than that in normal renal function.
Therefore, the present study was devised to establish an experimental renal dysfunctional dog model and to compare this model with a normal animal as to the change in blood pressure in the case of HD. Furthermore, we studied the relationship of NO to HD-related hypotension in this model by measuring the plasma NOx concentration. The half-life of NO in vivo is very short, making direct measurement of NO difficult. Therefore, we measured the plasma concentration of NOx, because NO readily reacts with oxygen in plasma to form NOx, which is a stable end product of NO metabolism [14] .
MATERIALS AND METHODS

Animals:
Twelve male beagle dogs (Keari Co., Ltd.) were used. The dogs were divided into a normal renal functional group and a renal dysfunctional group. Food was offered once daily and water was offered ad libitum.
Renal dysfunction: After premedication with atropine sulfate (0.05 mg/kg, sc) , each dog was anesthetized with medetomidine hydrocloride (25 mg/kg, im) and ketamine hydrocloride (10 mg/kg, im). Then inhalational anesthesia was maintained with isoflurane (2% nitrous oxide and oxygen). Through an abdominal section, 3 of 4 branches of the left renal artery were stripped and ligated. Two weeks later, the dogs were anesthetized again and all branches of the right renal artery were stripped and ligated. After another 2 weeks, the dogs were intramuscularly injected with 30 mg/ kg of gentamicin for one or two days. The extent of renal failure was confirmed by an increase in BUN (40 mg/dl or more).
Hemodialysis (HD):
In each animal, an arteriovenous shunt was created under the same anesthesia as mentioned above. Shunt catheters were inserted into the carotid artery and the jugular vein. Each catheter was led out subcutaneously and both of them were joined. Then another catheter was inserted into the femoral artery for measurement of blood pressure. Antibiotics were given after the operation. From the next day, HD was started. Conscious dogs were placed in a fixation frame, and HD was done for 180 min per day for 2 or 3 days with a hemodialysis system for animals (NBM-1000, Senko Medical Instrument Co., Ltd.). Each HD session was followed by a 120 min post-HD observation period. Before HD, the dogs were injected intravenously with heparin (100 U/kg) and 50 U/kg was added into the venous side of the circuit at 60 and 120 min after the start of HD to prevent clotting. HD was performed with a cellulose diasetate dialyzer membrane (1.1 m 2 ) (M ELTRA NOVA110, Althin Medical Inc., U.S.A.) , at a blood flow rate of 60 ml/min and a dialysate flow rate of 500 ml/min. Study protocol: The first HD was performed for acclimatization. In the third HD, infusion of L-NMMA (0.1 mg/kg/ min) was started at 30 min after the start of HD and continued for 150 min. L-NMMA was given via the venous line of the arteriovenous fistula at a flow rate of 40 ml/kg/hr (L-NMMA-treated group). Physiological saline without L-NMMA was administered in the same way (vehicle control group).
Heart rate (HR) was monitored from lead II of the electrocardiogram. Mean blood pressure (MBP) was measured via the femoral arterial catheter, which was connected to an amplifier (BIOVIEW 1000 PB1412/1-CF, NEC). Blood samples were collected from the arterial line of the arteriovenous fistula. The red blood cell count (RBC), white blood cell count (WBC), platelet count, and packed cell volume (PCV) were measured with an automated cytometer (Celica α MEK-6258, Nihon Kohden, Tokyo). BUN and creatinine in the renal dysfunction dogs were determined by means of a biochemistry autoanalyzer (VET TEST 8008, Aidex Laboratories). Protein was removed from a plasma sample by means of an ultrafilter (Ultrafree-MC 10,000NMWL, Millipore), and the plasma concentration of NOx was determined spectrophotometrically by the Griess method (Nitrate/nitrite colorimetric assay kit, Cayman Chemical). The measurement of hemodynamic parameters and collection of blood samples were performed before HD, every 30 min throughout the entire HD session, and 60 and 120 min after the end of HD. BUN and creatinine were determined before HD and every 60 min throughout the entire HD session.
Statistical analysis: Results are expressed as the mean ± S.E.M. Statistical significance was examined by Student's t-test and P values of less than 0.05 were considered significant.
RESULTS
Effect of HD in normal renal functional dogs and renal dysfunctional dogs:
Changes in MBP, HR, RBC, WBC, platelet count, PCV and NOx concentrations from before HD to 120 min after the end of HD are summarized in Table   1 . In normal renal functional dogs, MBP was noticeably decreased at 30 min (72.3 ± 5.6 mmHg, pre-HD value: 103.0 ± 7.5 mmHg) after the start of HD. This response was gradually restored to the pre-HD value, irrespective of the continuous practise of HD (Table 1) . HR increased from the start of HD and a significant increase was obtained at 90 min, and then MBP began to return to the pre-value. In renal dysfunctional dogs, MBP began to decrease at 30 min and was noticeably decreased at 120 min (92.1 ± 5.8 mmHg, pre-HD value: 115.6 ± 5.8 mmHg) after the start of HD. The fall in MBP was maintained during HD (Table 1) . HR was not changed throughout the HD (Table 1) . Renal dysfunctional dogs had an abnormal level renal function parameters (BUN: 93.1 ± 23.6 mg/dl, creatinine: 5.3 ± 0.9 mg/dl). These levels were gradually decreased by HD (Fig 1) . WBC was a lower in renal dysfunction dogs than in normal renal functional dogs. WBC noticeably decreased at 30 min after the start of HD and gradually resolved during HD in both groups (Table 1) . On the other hand, the platelet count increased in renal dysfunctional dogs in comparison with normal renal functional dogs. Platelets had decreased at 30 min after the start of HD and the decrease continued during HD in both groups (Table 1) . PCV did not have any change in either group. Renal dysfunctional dogs had significantly higher plasma NOx concentrations (28.2 ± 6.7 µM vs. 5.2 ± 2.4 µM) than normal renal functional dogs (Table 1) . In normal renal functional dogs, the plasma NOx concentration increased in the early HD phase, but not significantly. The plasma NOx concentration in renal dysfunctional dogs increased gradually up to 150 min after the start of HD and was maintained at a high level until 120 min after the termination of HD (Table 1) .
Effect of L-NMMA on HD-related hypotension in renal dysfunctional dogs: As shown in Fig. 1 , an infusion of L-NMMA at a flow rate of 0.1 mg/kg/min increased the significantly reduced MBP when compared with that of vehicle during the HD sessions. MBP returned to the pre-HD value at 120 min after administration of L-NMMA (Fig. 1) . The infusion of L-NMMA tended to prevent an increase in the plasma NOx concentration, but it was not significantly different from the vehicle group (Fig. 1) . HR was not affected by the infusion of L-NMMA. L-NMMA did not have any effect on BUN or creatinine clearance (Fig. 1) , indicating that L-NMMA does not affect HD-efficiency.
DISCUSSION
In this study, we made the renal dysfunctional dogs by ligating 7 of 8 renal artery branches and administering of gentamicin. Since the plasma level of BUN in this model dog was 3 times higher than that in normal renal functional dogs, it was confirmed that this model has a high extent of renal failure. The HD session for the renal dysfunctional dogs produced continuous hypotension during HD. On the other hand, in normal renal functional dogs, the HD session induced transient hypotension. It is well known that hypotension in patients with renal dysfunction continues during HD [9] . These results indicate that a HD session in renal dysfunction induces continuous hypotension through different mechanisms from that in normal renal function. Thus, the renal dysfunctional dog model, which produces a similar hemodynamic change to patients with renal dysfunction, is proved useful for investigating mechanisms concerning HD-related hypotension.
Infusion of L-NMMA, a non-selective NOS inhibitor, at a dose of 0.1 mg/kg/min has been used to investigate the involvement of NO in the regulation of blood pressure [10] , and it caused a 10 mmHg increase in the MBP of normal dogs (data not shown). In the present study, L-NMMA ameliorated a late phase of HD-related hypotension in renal dysfunctional dogs. This suggests that NO plays an important role in the continuous hypotension induced by HD. In addition, we obtained results showing that the activity of NO synthesis accelerates in renal dysfunctional dogs. First, the plasma NOx concentration at predialysis was higher in renal dysfunctional dogs than in normal renal functional dogs. Second, the increases in the plasma NOx concentration during HD in renal dysfunctional dogs were 20 µM or more, whereas those in normal renal functional dogs were not significant. It is known that in uremic patients NO synthase activity is higher than in healthy volunteers and increases during HD [17] , and plasma levels of IL-1 and TNF, which are powerful inducers of iNOS, chronically increase [6] . Therefore, the results obtained in the present study further support the possibility that HD-related hypotension in renal disease patients is mediated by the overproduction of NO. On the other hand, L-NMMA slightly decreased the plasma NOx concentration in renal dysfunctional dogs, although the decrease was not statistically significant. This result seems inconsistent with the NO hypothesis based on blood pressure. Nevertheless, a similar phenomenon, i.e. that subcutaneous administration of the NO synthase inhibitor prevents hypotension in response to lipopolysaccharide (LPS) in rats, but does not restore an increase in the plasma NOx concentration is reported [11] . LPS causes NO production by activating monocytes or macrophages through cytokines [14] . As mentioned above, the plasma concentrations of cytokines, IL-1 and TNF, increases under the condition of renal dysfunction [6] . Therefore, the increase in the plasma NOx concentration during HD may originate mainly in NO produced from monocytes or macrophages. Since the importance of eNOS is indicated in the regulation of MBP [14] , it seems likely that the inhibition of eNOS is associated with an increase in MBP but not in that of iNOS. The decrease in NO through eNOS inhibition caused by L-NMMA might be masked by the overproduction of NO in renal dysfunctional dogs.
In normal renal functional dogs, HD caused acute hypotension without any significant increase in the NOx concentration. About 100 ml of blood volume was transiently removed at the start of HD to extracorporeal circulation in the present study. Hypovolemia produces a decrease in MBP. Thus, the hypotension in an early phase of HD may be due to a transient decrease in blood volume. This could also explain a dissociation between the hypotension and plasma concentrations of NOx in an early phase of HD (until 30-60 min after the start of HD) in renal dysfunctional dogs.
A fall in blood pressure causes an increase in the activity of the sympathetic nervous system with a subsequent increase in HR, which partially restores blood pressure [5] . The restoration of MBP was paralleled by the increase in HR in normal renal functional dogs. On the other hand, no increase in HR was observed in renal dysfunctional dogs, in spite of the continuous reduction in MBP. It is shown that patients with renal dysfunction have autonomic dysfunction [13] and NO reduces sympathetic activity [4] . These results suggest that an excessive production of NO suppresses the sympathetic nerve activity in renal dysfunctional dogs. But, since L-NMMA did not have any effect on HR during HD in renal dysfunctional dogs, the restoration of HD-related hypotension with L-NMMA may not be due to any effect on sympathetic nerve activity.
In the present study, the differences between normal renal functional and renal dysfunctional dogs were further observed in the components of blood. WBC decreased significantly in renal dysfunctional dogs. But we have no other definite information concerning this result. The reason why WBC decreased during HD may be due to an adhesion to the dialyzer membrane [2, 7] . It has been shown that uremia results in platelet dysfunction [16] . An increase in platelets in renal dysfunctional dogs may result from compensation for the dysfunction.
In conclusion, our data suggest that excessive production of NO contributes to HD-related hypotension in renal dysfunction, but the plasma NOx concentration did not reflect the change in MBP. Since infusion of L-NMMA ameliorated HD-related hemodynamic changes without affecting HD efficiency, the inhibition of NO production may be beneficial in HD-related hypotension. Therefore, it is possible that NOS inhibitor is expected to provide an efficient therapy for the prevention of HD-related hypotension.
